LCD Solution Versus Calcipotriol Cream in the Treatment of Moderate Plaque Psoriasis

A Randomized, Single-Blind, Active Control, 18-Week Study to Evaluate the Safety and Efficacy of A New Twice-Daily, Topically Applied LCD Solution vs. Calcipotriol Cream for the Treatment of Adult Subjects With Moderate Plaque Psoriasis

The purpose of this study is to compare the safety and effectiveness of a new topical LCD solution and a commercially available calcipotriol (Vitamin D) cream in reducing the symptoms of plaque psoriasis and improving the quality of life in adults.

Inclusion Criteria:

• 18 years of age or older
• able and willing to provide written informed consent
• diagnosed with chronic plaque psoriasis
• 3% to 15% body surface area involved
• in good general health

Exclusion Criteria:

• other current treatments for psoriasis
• renal or liver dysfunction
• pregnant or nursing